Medical Condition News

RSS

Heavy drinking now poses greater liver disease risk than two decades ago

Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, according to a new Keck Medicine of USC study published today in Clinical Gastroenterology and Hepatology.

23 Jul 2025

Weill Cornell Medicine launches study to advance treatments for rare neurological disorder

A $1.1 million grant from the parent-caregiver-led Rare Bird Foundation to Weill Cornell Medicine is supporting the launch of a natural history study for a rare neurodevelopmental disorder that causes developmental delays and seizures called MEF2C Haploinsufficiency syndrome (MCHS).

23 Jul 2025

Novel DNA plasmid therapy shows high success rate in treating chronic pain in dogs

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain demonstrating a 90% success rate.

23 Jul 2025

New collaborative effort harnesses AI to drive ALS drug discovery in Louisiana

Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases.

23 Jul 2025

STRIDE immunotherapy sets new benchmark for survival in advanced liver cancer

A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma (uHCC, an advanced liver cancer that could not be treated with surgery or other localized treatments) has shown that one in five (19.6%) participants treated with STRIDE (Single Tremelimumab Regular Interval Durvalumab) a combination of two immunotherapies, remained alive after five years of follow-up versus one in 10 (9.4%) participants treated with sorafenib, a standard treatment for uHCC when the study was designed.

23 Jul 2025

EU initiative puts nutrition at the heart of diabetes care

Managing type 2 diabetes isn't just about medicine—it's also about what's on your plate. Cook2DIAbeat is a new EU-supported initiative that puts food front and centre in the fight against diabetes.

23 Jul 2025

New project aims to boost screening for cardiovascular disease marker in community health centers

Elevated lipoprotein(a), also known as Lp(a), is an independent, inherited and causal risk factor for cardiovascular disease, the leading cause of death and disability worldwide.

23 Jul 2025

Intranasal insulin safely and effectively reaches key memory regions of the brain

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer's disease treatments: Intranasal insulin, delivered via a simple nasal spray, safely and effectively reaches key memory regions of the brain in older adults.

23 Jul 2025

New diagnostic test identifies head and neck cancer patients curable by surgery alone

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for radiation or chemotherapy.

23 Jul 2025

Long-term air pollution exposure triggers allergic immune responses in the lungs

Air pollution is a global health concern, with over 90% of the world's population breathing air that exceeds World Health Organization safety standards.

23 Jul 2025

Substance use disorders increase risk of unplanned hospital readmissions

People with any type of substance use disorder (SUD) stand a 24% higher risk of having an unplanned hospital readmission within 30 days of a previous discharge compared with those without the disorder, new UCLA-led research finds.

23 Jul 2025

Liupao tea improves metabolic syndrome risks in clinical trial

Liupao tea shows promise in improving metabolic syndrome markers, enhancing heart health and gut balance in just three months, according to recent research.

23 Jul 2025

Machine learning improves prediction of death risk in hospitalized cirrhosis patients

Researchers employed a machine learning technique known as random forest analysis and found that it significantly outperformed traditional methods in predicting which hospitalized patients with cirrhosis are at risk of death, according to a new paper published in Gastroenterology.

23 Jul 2025

Deep-sea bacterial compound triggers pyroptosis to fight cancer

Promoting pyroptosis-an inflammatory form of programmed cell death-has become a promising treatment strategy for cancer.

23 Jul 2025

Polygenic scores show promise for early obesity prevention

New genetic research reveals polygenic scores can predict obesity risk, offering early prevention insights while raising ethical healthcare access concerns.

23 Jul 2025

Targeting tumor cell stemness may hold the key to treating colon cancer more effectively

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of cancer-related death worldwide.

22 Jul 2025

New approach doubles chemotherapy effectiveness by targeting cancer cell memory

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of chemotherapy in animal experiments.

22 Jul 2025

New analysis reveals hidden economic burden of PTSD in the UK

The annual UK cost of the mental health disorder PTSD is likely to top £40 billion, but the figures are based on 2020-1 prevalence rates-the most recently available-and don't include many indirect costs, such as family support services, finds a cost analysis published in the open access journal BMJ Open.

22 Jul 2025

Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide significant benefits for cardiovascular, kidney, liver, joint, and sleep-related diseases. These effects extend beyond weight loss, suggesting anti-inflammatory mechanisms with broad potential for managing chronic diseases.

22 Jul 2025

GLP-1 receptor agonists linked to lower dementia risk in type 2 diabetes

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, published in the open access journal BMJ Open Diabetes Research & Care.

22 Jul 2025

Medical Condition News

Heavy drinking now poses greater liver disease risk than two decades ago

Weill Cornell Medicine launches study to advance treatments for rare neurological disorder

Novel DNA plasmid therapy shows high success rate in treating chronic pain in dogs

New collaborative effort harnesses AI to drive ALS drug discovery in Louisiana

STRIDE immunotherapy sets new benchmark for survival in advanced liver cancer

EU initiative puts nutrition at the heart of diabetes care

New project aims to boost screening for cardiovascular disease marker in community health centers

Intranasal insulin safely and effectively reaches key memory regions of the brain

New diagnostic test identifies head and neck cancer patients curable by surgery alone

Long-term air pollution exposure triggers allergic immune responses in the lungs

Substance use disorders increase risk of unplanned hospital readmissions

Liupao tea improves metabolic syndrome risks in clinical trial

Machine learning improves prediction of death risk in hospitalized cirrhosis patients

Deep-sea bacterial compound triggers pyroptosis to fight cancer

Polygenic scores show promise for early obesity prevention

Targeting tumor cell stemness may hold the key to treating colon cancer more effectively

New approach doubles chemotherapy effectiveness by targeting cancer cell memory

New analysis reveals hidden economic burden of PTSD in the UK

Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists

GLP-1 receptor agonists linked to lower dementia risk in type 2 diabetes

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News